Theoretical dissolution model of poly-disperse drug particles in biorelevant media

Journal of Pharmaceutical Sciences

Volumn 97, Issue 5, 2008, Pages 1843-1852

  Okazaki, Arimichi ^a   Mano, Takashi ^a   Sugano, Kiyohiko ^a  

^a PFIZER INC   (United States)

Author keywords

Absorption; Dissolution; Gastrointestinal; Particle size; Phospholipids; Surfactants

Indexed keywords

BILE SALT; DANAZOL; GRISEOFULVIN; PHOSPHATIDYLCHOLINE; TAUROCHOLIC ACID; DRUG;

ACCURACY; ARTICLE; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG SOLUBILITY; MICELLE; PARTICLE SIZE; POWDER; PREDICTION; THEORETICAL MODEL; CHEMISTRY; DIFFUSION; SOLUBILITY;

DIFFUSION; MODELS, THEORETICAL; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 48549102969     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21070     Document Type: Article

References (42)

1. Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, Shah VP, Lesko LJ, Chen ML, Lee VH, Hussain AS. 2002. Biopharmaceutics classification system: The scientific basis for biowaiver extensions. Pharm Res 19:921-925.
2. Sugano K, Obata K, Saitoh R, Higashida A, Hamada H. 2006. Processing of biopharmaceutical profiling data in drug discovery. In: Testa B, Krämer SD, Wunderli-Allenspach H, Folkers G, Guy R, editors. Pharmacokinetic profiling in drug research. Zurich: Wiley-VCH. pp 441-458.
3. Lipinski CA. 2000. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235-249.
4. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25.
5. Bevan CD, Lloyd RS. 2000. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in micro-titer plates. Anal Chem 72:1781-1787.
6. Kerns EH. 2001. High throughput physicochemical profiling for drug discovery. J Pharm Sci 90:1838-1858.
7. Roy D, Ducher F, Laumain A, Legendre JY. 2001. Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay. Drug Dev Ind Pharm 27:107-109.
8. Avdeef A. 2001. Physicochemical profiling (solubility, permeability and charge state). Curr Top Med Chem 1:277-351.
9. Obata K, Sugano K, Machida M, Aso Y. 2004. Biopharmaceutics classification by high throughput solubility assay and PAMPA. Drug Dev Ind Pharm 30:181.
10. Sugano K, Kato T, Suzuki K, Keiko K, Sujaku T, Mano T. 2006. High throughput solubility measurement with automated polarized light microscopy analysis. J Pharm Sci 95:2115-2122.
11. Persson EM, Gustafsson A-S, Carlsson AS, Nilsson RG, Knutson L, Forsell P, Hanisch G, Lennernas H, Abrahamsson B. 2005. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 22:2141-2151.
12. Naylor LJ, Bakatselou V, Dressman JB. 1993. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm Res 10:865-870.
13. Rao VM, Lin M, Larive CK, Southard MZ. 1997. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions. J Pharm Sci 86:1132-1137.
14. Sun W, Larive CK, Southard MZ. 2003. A mechanistic study of danazol dissolution in ionic surfactant solutions. J Pharm Sci 92:424-435.
15. Balakrishnan A, Rege BD, Amidon GL, Polli JE. 2004. Surfactant-mediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity. J Pharm Sci 93:2064-2075.
16. Kouchiwa S, Nemoto M, Itai S, Murayama H, Nagai T. 1985. Prediction of available surface area of powdered particles of flufenamic acid in tablets. Chem Pharm Bull 33:1641-1651.
17. Kouchiwa S, Nemoto M, Itai S, Murayama H, Nagai T. 1985. Dissolution profiles of nalidixic acid powders having weibull particle size distribution. Chem Pharm Bull 33:2452-2460.
18. Itai S, Nemoto M, Kouchiwa S, Murayama H, Nagai T. 1985. Influence of wetting factors on the dissolution behavior of flufenamic acid. Chem Pharm Bull 33:5464-5473.
19. Itai S, Kouchiwa S, Nemoto M, Murayama H, Nagai T. 1986. Effect of compression pressure and formulation on the available surface area of flufenamic acid in tablets. Chem Pharm Bull 34:1264-1274.
20. Hintz RJ, Johnson KC. 1989. The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm 51:9-17.
21. Johnson KC, Swindell AC. 1996. Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharm Res 13:1795-1798.
22. Galia E, Nicolaides E, Horter D, Lobenberg R, Reppas C, Dressman JB. 1998. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 15:698-705.
23. Nicolaides E, Galia E, Efthymiopoulos C, Dressman JB, Reppas C. 1999. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data. Pharm Res 16:1876-1882.
24. Nicolaides E, Symillides M, Dressman JB, Reppas C. 2001. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm Res 18:380-388.
25. Kataoka M, Masaoka Y, Sakuma S, Yamashita S. 2006. Effect of food intake on the oral absorption of poorly water-soluble drugs: In vitro assessment of drug dissolution and permeation assay system. J Pharm Sci 95:2051-2061.
26. Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, Yamashita S. 2006. Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res 23:1144-1156.
27. Nernst W. 1904. Theorie der Reaktionsgeschwin-digkeit in heterogenen Systemen. Z Phys Chem 47: 52-55.
28. Dokoumetzidis A, Macheras P. 2006. A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm 321:1-11.
29. Jinno J-i, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. 2006. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 111:56-64.
30. Chakrabarti S, Southard MZ. 1996. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 1. Effect of tablet geometry in buffered medium. J Pharm Sci 86:313-319.
31. Chakrabarti S, Southard MZ. 1997. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 2. Cocom-pression of drugs with buffers. J Pharm Sci 86:465-469.
32. Harriott P. 1962. Mass transfer to particles: Part 1. Suspended inagitated tanks. A ICHE J 8:93-102.
33. Aoyagi N, Ogata H, Kaniwa N, Ejima A. 1982. Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets. J Pharmacobio-Dyn 5:120-124.
34. Charman WN, Rogge MC, Boddy AW, Berger BM. 1993. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol 33:381-386.
35. Lichtenberg D, Opatowski E, Kozlov MM. 2000. Phase boundaries in mixtures of membrane-forming amphiphiles and micelle-forming amphiphiles. Biochim Biophys Acta 1508:1-19.
36. Sunesen VH, Pedersen BL, Kristensen HG, Mullertz A. 2005. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Eur J Pharm Sci 24:305-313.
37. Ilardia-Arana D, Kristensen HG, Mullertz A. 2006. Biorelevant dissolution media: Aggregation of amphiphiles and solubility of estradiol. J Pharm Sci 95:248-255.
38. Parrott N, Lave T. 2002. Prediction of intestinal absorption: Comparative assessment of GASTRO-PLUS and IDEA. Eur J Pharm Sci 17:51-61.
39. Kuentz M, Nick S, Parrott N, Rothlisberger D. 2006. A strategy for preclinical formulation development using GastroPlus(TM) as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. Eur J Pharm Sci 27:91-99.
40. Glomme A, März J, Dressman JB. 2006. Predicting the intestinal solubility of poorly soluble drugs. In: Testa B, Krämer SD, Wunderli-Allenspach H, Folkers G, Guy R, editors. Pharmacokinetic profiling in drug research. Zurich: Wiley-VCH. pp 260-280.
41. Mannhold R. 2006. Calculation of lipophilicity: A classification of methods. In: Testa B, Krämer SD, Wunderli-Allenspach H, Folkers G, Guy R, editors. Pharmacokinetic profiling in drug research. Zurich: Wiley-VCH. pp 333-352.
42. Delaney JS. 2005. Predicting aqueous solubility from structure. Drug Discov Today 10:289-295.